News
Contact Us
Site Search:
About Us
Directors and Management
Scientists
Corporate Governance
Board Charter
Code of Conduct
Audit Committee Charter
Nomination Committee Charter
Continuous Disclosure Policy
Share Trading Policy
Risk Management Policy
Social Media Policy
Performance Evaluation Process
Corporate Code of Conduct
Corporate Governance Statements
Careers
Technology
Midkine Publications
Key Publications
Key Patents and IP
List of Key Patents
Pipeline
Therapeutics
Lyramid
Kinera
Diagnostic
Market Potential
Lyramid: Cancer Treatment and Detection
Lyramid: Inflammatory and Fibrotic Diseases
Kinera: Ischemic Disease
Products
Midkine ELISA Kit
Evolis Products
Shareholder Information
Public Disclosure Policy
ASX Company Announcements - 2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Cellmid in the Media
PharmaTelevision: Midkine Symposium 2016
2018 MK Symposium
2016 Conference wrap up
2016 Program
2016 Gallery
2014 Conference wrap up
2014 Program
2014 Gallery
2012 Conference wrap up
2012 Program
2012 Gallery
2012 Conference Venue
2010 Conference wrap up
Gallery
2010 Program
Contact Conference Committee
Corporate Governance Statements
27 Sep 2018
Corporate Governance Statement 2018
Also in this section
About Us
»
Corporate Governance
»
Corporate Governance Statements
Directors and Management
Scientists
Corporate Governance
Board Charter
Code of Conduct
Audit Committee Charter
Nomination Committee Charter
Continuous Disclosure Policy
Share Trading Policy
Risk Management Policy
Social Media Policy
Performance Evaluation Process
Corporate Code of Conduct
Corporate Governance Statements
Careers